W, Y., K, P., N, D., CM, T., B, C., H, M., . . . S, K. M. (2025). PLAN-psoriasis: Protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis. BMJ open, 15(10), e106635. https://doi.org/10.1136/bmjopen-2025-106635
Chicago Style (17th ed.) CitationW, Ye, et al. "PLAN-psoriasis: Protocol for a Randomised Controlled Feasibility Trial Comparing Patient-led 'As-needed' Treatment and Therapeutic Drug Monitoring-guided Treatment to Continuous Treatment for Adults with Clear or Almost Clear Skin on Risankizumab Monotherapy for Psoriasis." BMJ Open 15, no. 10 (2025): e106635. https://doi.org/10.1136/bmjopen-2025-106635.
MLA (9th ed.) CitationW, Ye, et al. "PLAN-psoriasis: Protocol for a Randomised Controlled Feasibility Trial Comparing Patient-led 'As-needed' Treatment and Therapeutic Drug Monitoring-guided Treatment to Continuous Treatment for Adults with Clear or Almost Clear Skin on Risankizumab Monotherapy for Psoriasis." BMJ Open, vol. 15, no. 10, 2025, p. e106635, https://doi.org/10.1136/bmjopen-2025-106635.
